Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease

Experimental Neurology

Volumn 145, Issue 1, 1997, Pages 245-252

  Boissiere, Florence ^a   Faucheux, Baptiste ^a   Ruberg, Merle ^a   Agid, Yves ^a   Hirsch, Etienne C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE ACETYLTRANSFERASE;

AGED; ALZHEIMER DISEASE; ARTICLE; CHOLINERGIC NERVE; CLINICAL ARTICLE; CORPUS STRIATUM; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION REGULATION; GROWTH REGULATION; HUMAN; IN SITU HYBRIDIZATION; MALE; NERVE CELL GROWTH; PRIORITY JOURNAL; PUTAMEN;

EID: 0031148892     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6443     Document Type: Article

References (41)

1. Bertrand P., Roger O., Houlgatte R., Javoy-Agid F., Brandel J.-P., Doble A., Blanchard J. C. Measurement of nerve growth factor-like immunoreactivity in the human brain using an anti-mouse-NGF enzyme immunoassay. Neurochem. Int. 20:1992;215-218.
2. Bisconte J. C., Fulcrand J., Marty R. Analyse radioautographique dans le système nerveux central par photométrie et cartographie combinée. C. R. Soc. Biol. 161:1968;2178-2182.
3. Bodian D. A new method for staining nerve fibres and nerve endings in mounted paraffin sections. Anat. Rec. 65:1936;89-98.
4. Boissière F., Hunot S., Faucheux B., Agid Y., Hirsch E. C. High affinity neurotrophin receptors in cholinergic neurons in the human brain. C. R. Acad. Sci. Paris Science de la vie/Life sciences. 317:1994;997-1003.
5. Boissière F., Hunot S., Faucheux B., Hersh L. B., Agid Y., Hirsch E. C. Trk neurotrophin receptors in cholinergic neurons of patients with Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 8:1997;1-8.
6. Boissière F., Faucheux B., Agid Y., Hirsch E. C. Expression of catalytic trkB gene in the striatum and the basal forebrain of patients with Alzheimer's disease: An in situ hybridization study. Neurosci. Lett. 221:1997;141-144.
7. Chao M. V. Neurotrophin receptors: a window into neuronal differentiation. Neuron. 9:1992;583-593.
8. Chesselet M.-F., Weiss L., Wuenschell C., Tobin A. J., Affolter H.-U. Comparative distribution of RNAs for glutamic acid decarboxylase, tyrosine hydroxylase and tachykinins in the basal ganglia: An in situ hybridization study in the rodent brain. J. Comp. Neurol. 262:1987;125-140.
9. Crutcher K. A., Scott S. A., Liang S., Everson W. V., Weingartner J. Detection of NGF-like immunoreactivity in human brain tissue: increased levels in Alzheimer's disease. J. Neurosci. 13:1993;2540-2550.
10. Davies P. Neurotransmitter-related enzymes in senile dementia of the Alzheimer type. Brain Res. 171:1979;319-327.
11. Davies S. W., Beardsall K. Nerve growth factor selectively prevents excitotoxin induced degeneration of striatal cholinergic neurons. Neurosci. Lett. 140:1992;161-164.
12. Dreyfus C. F. Effects of nerve growth factor on cholinergic brain neurons. Trends Pharmacol. Sci. 10:1989;145-149.
13. Ernfors P., Linderfors N., Chan-Palay V., Persson H. Cholinergic neurons of the nucleus basalis express elevated levels of nerve growth factor receptor mRNA in senile dementia of the Alzheimer type. Dementia. 1:1990;138-145.
14. Fontaine B., Sassoon D., Buckingham M., Changeux J.-P. Detection of the nicotinic acetylcholine receptor subunit mRNA by in situ hybridization at neuromuscular junction of 15-day old chick striatal muscles. EMBO J. 7:1988;603-609.
15. Goedert M., Fine A., Hunt S. P., Ullrich A. Nerve growth factor mRNA in the peripheral and central rat tissues and in human central nervous system: Lesion effects in the rat brain and levels in Alzheimer's disease. Mol. Brain Res. 1:1986;85-92.
16. Goedert M., Fine A., Dawbarn D., Wilcock G. K., Chao M. V. Nerve growth factor receptor mRNA distribution in the human brain: Normal levels in basal forebrain in Alzheimer's disease. Mol. Brain Res. 5:1989;1-7.
17. Graybiel A. M., Ragsdale C. W. Histochemically distinct compartments in the striatum of human, monkey and cat demonstrated by acetylcholinesterase staining. Proc. Natl. Acad. Sci. USA. 75:1978;5723-5726.
18. trk. Neuron. 9:1992;465-478.
19. Javoy-Agid F., Hirsch E. C., Dumas S., Duyckaerts C., Mallet J., Agid Y. Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study. Neuroscience. 38:1990;245-253.
20. Kaplan D. R., Hempstead B. L., Martin-Zanca D., Chao M. V., Parada L. F. The trk proto-oncogene product: A signal transducing receptor for nerve growth factor. Science. 252:1991;554-558.
21. Koliatsos V. E., Nauta H. J. W., Clatterbuck R. E., Holtzman D. M., Mobley W. C., Price D. L. Mouse nerve growth factor prevents degeneration of axotomized basal forebrain cholinergic neurons in the monkey. J. Neurosci. 10:1990;3801-3813.
22. Kordower J. H., Chen E.-Y., Sladek J. R., Mufson E. J. Trk-immunoreactivity in the monkey central nervous system: Forebrain. J. Comp. Neurol. 349:1994;20-35.
23. Lehéricy S., Hirsch E. C., Cervera P., Hersh L. B., Hauw J.-J., Ruberg M., Agid Y. Selective loss of cholinergic neurons in the ventral striatum of patients with Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 86:1989;8580-8584.
24. Lehéricy S., Hirsch E. C., Cervera-Piérot P., Hersh L. B., Bakchine S., Piette F., Duyckaerts C., Hauw J.-J., Javoy-Agid F., Agid Y. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease. J. Comp. Neurol. 330:1993;15-31.
25. 67. Eur. J. Neurosci. 7:1995;1199-1209.
26. Merlio J. P., Ernfors P., Jaber M., Persson H. Molecular cloning of rat trkC and distribution of cells expressing messenger RNAs for member of the trk family in the rat central nervous system. Neuroscience. 51:1992;513-532.
27. Mesulam M.-M., Geula C. Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: Observations based on the distribution of acetylcholinesterase and choline acetyltransferase. J. Comp. Neurol. 275:1988;216-240.
28. Montfort J.-C., Javoy-Agid F., Hauw J.-J., Dubois B., Agid Y. Brain glutamate decarboxylase in Parkinson's disease with particular reference to a premortem severity index. Brain. 108:1985;301-313.
29. Mufson E. J., Conner J. M., Kordower J. H. Nerve Growth factor in Alzheimer's disease: Defective retrograde transport to nucleus basalis. Neuroreport. 6:1995;1063-1066.
30. Mufson E. J., Li J.-M., Sobrieviela T., Kordower J. H. Decreased trkA gene expression within basal forebrain neurons in Alzheimer's disease. Neuroreport. 8:1997;25-29.
31. Rossor M. N., Garret N. J., Johnson A. L., Mountjoy C. Q., Roth M., Iversen L. L. A post-mortem study of the cholinergic and GABA systems in senile dementia. Brain. 105:1982;313-330.
32. Salehi A., Lucassen P. J., Pool C. W., Gonatas N. K., Ravid R., Swaab D. F. Decreased neuronal activity in the nucleus basalis of Meynert in Alzheimer's disease as suggested by the size of the Golgi apparatus. Neuroscience. 59:1994;871-880.
33. Salehi A., Verhaagen J., Dijkhuizen P. A., Swaab D. F. Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease. Neuroscience. 75:1996;373-387.
34. Scott S. A., Mufson E. J., Weingartner J. A., Skau K. A., Crutcher K. A. Nerve growth factor in Alzheimer's disease: Increased levels throughout the brain coupled with declines in nucleus basalis. J. Neurosci. 15:1995;6213-6221.
35. Scott S. A., Crutcher K. A. Nerve growth factor and Alzheimer's disease. Rev. Neurosci. 5:1994;179-211.
36. Selden N., Mesulam M.-M., Geula C. Human striatum: the distribution of neurofibrillary tangles in Alzheimer's disease. Brain Res. 648:1994;327-331.
37. Shelton D. L., Sutherland J., Gripp J., Camerato T., Armanini M. P., Phillips H. S., Carroll K., Spencer S. D., Levinson A. D. Human trks: Molecular cloning, tissue distribution, and expression of extracellular domain immunoadhesins. J. Neurosci. 15:1995;477-491.
38. Strada O., Hirsch E. C., Javoy-Agid F., Lehéricy S., Ruberg M., Hauw J.-J., Agid Y. Does loss of nerve growth factor receptors precede loss of cholinergic neurons in Alzheimer's disease? An autoradiographic study in the human striatum and basal forebrain. J. Neurosci. 12:1992;4766-4774.
39. Strada O., Vyas S., Hirsch E. C., Ruberg M., Brice A., Agid Y., Javoy-Agid F. Decreased choline acetyltransferase mRNA expression in the nucleus basalis of Meynert in Alzheimer disease: An in situ hybridization study. Proc. Natl. Acad. Sci. USA. 89:1992;9549-9553.
40. Woolf N. J., Jacobs R. W., Butcher L. L. The pontomesencephalotegmental cholinergic system does not degenerate in Alzheimer's disease. Neurosci. Lett. 96:1989;277-282.
41. Zhou J., Valletta J. S., Grimes M. L., Mobley W. C. Multiple levels for regulation of TrkA in PC12 cells by nerve growth factor. J. Neurochem. 65:1995;1146-1156.